Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Therapeutic Drug Carrier Systems
Factor de Impacto: 2.9 Factor de Impacto de 5 años: 3.72 SJR: 0.736 SNIP: 0.551 CiteScore™: 2.43

ISSN Imprimir: 0743-4863
ISSN En Línea: 2162-660X

Volumen 36, 2019 Volumen 35, 2018 Volumen 34, 2017 Volumen 33, 2016 Volumen 32, 2015 Volumen 31, 2014 Volumen 30, 2013 Volumen 29, 2012 Volumen 28, 2011 Volumen 27, 2010 Volumen 26, 2009 Volumen 25, 2008 Volumen 24, 2007 Volumen 23, 2006 Volumen 22, 2005 Volumen 21, 2004 Volumen 20, 2003 Volumen 19, 2002 Volumen 18, 2001 Volumen 17, 2000 Volumen 16, 1999 Volumen 15, 1998 Volumen 14, 1997 Volumen 13, 1996 Volumen 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v15.i1.20
32 pages

The Interaction of Liposomes with the Complement System

Janos Szebeni
Department of Membrane Biochemistry, Walter Reed Army Institute of Research, 503 Robert Grant Avenue Silver Spring, MD 20910-7580


Activation of complement (C) by haptenized liposomes has been utilized for a long time to study the interaction of biological membranes with C proteins, or as a sensitive immunoassay for the measurement of specific antigens, antibodies, or serum hemolytic C levels. However, it has been increasingly recognized that regardless of antigenicity, C activation is an intrinsic property of all charged phospholipid/cholesterol bilayers. Liposome-induced C activation and its biological consequences show significant interspecies and interindividual variation, and critically depend on the properties of vesicles as well. Activation can proceed through both the classical and the alternative pathways, with or without the involvement of antibodies. The practical significance of the phenomenon is twofold: 1) opsonization of the vesicles promotes their clearance from the circulation and 2) the liberation of C3a and C5a can cause numerous, potentially adverse, biological reactions. In fact, many cardiovascular and hematological changes observed following administration of liposomes in vivo can be explained by C activation; a fact that has not yet gained wide recognition in the field of drug-carrier liposomes.

Articles with similar content:

Bacterial Toxins in Cancer Immunotherapy
Forum on Immunopathological Diseases and Therapeutics, Vol.4, 2013, issue 3-4
Lenka Sadilkova, Irena Adkins, Lenka Palova-Jelinkova
The Phylogeny of Alpha-Fetoprotein in Vertebrates: Survey of Biochemical and Physiological Data
Critical Reviews™ in Eukaryotic Gene Expression, Vol.5, 1995, issue 3-4
G.J. Mizejewski
Physiological-Biochemical Response of Fish to the Pesticide Effect (a Review)
Hydrobiological Journal, Vol.46, 2010, issue 4
L. O. Gorbatiuk
Heavy-Chain-Only Antibody Expression and B-Cell Development in the Mouse
Critical Reviews™ in Immunology, Vol.26, 2006, issue 5
Jennifer A. Smith, Marianne Bruggemann, Xiangang Zou, Serge Muyldermans, Daniel Corcos, Viet Khong Nguyen, Michael J. Osborn
Role of Galectin-3 in the Initial Control of Leishmania Infection
Critical Reviews™ in Immunology, Vol.34, 2014, issue 2
Guillaume St-Pierre, Pampa Bhaumik, Isabelle Pelletier, Sachiko Sato